Aimee Readie

2.0k total citations
28 papers, 1.4k citations indexed

About

Aimee Readie is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Aimee Readie has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 14 papers in Immunology and 10 papers in Hematology. Recurrent topics in Aimee Readie's work include Spondyloarthritis Studies and Treatments (22 papers), Rheumatoid Arthritis Research and Therapies (17 papers) and Psoriasis: Treatment and Pathogenesis (12 papers). Aimee Readie is often cited by papers focused on Spondyloarthritis Studies and Treatments (22 papers), Rheumatoid Arthritis Research and Therapies (17 papers) and Psoriasis: Treatment and Pathogenesis (12 papers). Aimee Readie collaborates with scholars based in United States, Switzerland and United Kingdom. Aimee Readie's co-authors include Brian Porter, Shephard Mpofu, Hanno B. Richards, Désirée van der Heijde, Robert Landewé, Hasan Tahir, Luminita Pricop, Xenofon Baraliakos, Jürgen Braun and Christina Bucci‐Rechtweg and has published in prestigious journals such as PLoS ONE, Scientific Reports and The American Journal of Human Genetics.

In The Last Decade

Aimee Readie

28 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aimee Readie United States 13 898 673 436 425 320 28 1.4k
Herbert Kellner Germany 17 762 0.8× 523 0.8× 307 0.7× 61 0.1× 108 0.3× 38 1.2k
A. Nzeusseu Toukap Belgium 14 549 0.6× 226 0.3× 144 0.3× 82 0.2× 114 0.4× 36 784
E. K. Li China 18 702 0.8× 427 0.6× 142 0.3× 66 0.2× 58 0.2× 23 934
S Songcharoen United States 6 421 0.5× 141 0.2× 184 0.4× 129 0.3× 104 0.3× 7 654
Phil Gallagher Ireland 15 942 1.0× 767 1.1× 419 1.0× 27 0.1× 45 0.1× 29 1.2k
Debby den Uyl Netherlands 13 330 0.4× 106 0.2× 129 0.3× 150 0.4× 121 0.4× 21 770
J. S. Smolen Austria 13 581 0.6× 184 0.3× 220 0.5× 47 0.1× 113 0.4× 24 948
G. Schett Germany 12 257 0.3× 246 0.4× 111 0.3× 29 0.1× 99 0.3× 51 644
M. Witt Germany 12 268 0.3× 207 0.3× 174 0.4× 37 0.1× 57 0.2× 36 761
Yasushi Nawata Japan 11 206 0.2× 337 0.5× 53 0.1× 108 0.3× 96 0.3× 16 717

Countries citing papers authored by Aimee Readie

Since Specialization
Citations

This map shows the geographic impact of Aimee Readie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimee Readie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimee Readie more than expected).

Fields of papers citing papers by Aimee Readie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aimee Readie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimee Readie. The network helps show where Aimee Readie may publish in the future.

Co-authorship network of co-authors of Aimee Readie

This figure shows the co-authorship network connecting the top 25 collaborators of Aimee Readie. A scholar is included among the top collaborators of Aimee Readie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aimee Readie. Aimee Readie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jamaludin, Amir, Sarim Ather, Timor Kadir, et al.. (2025). Automated detection of spinal bone marrow oedema in axial spondyloarthritis: training and validation using two large phase 3 trial datasets. Lara D. Veeken. 64(10). 5446–5454. 1 indexed citations
2.
Chen, Yao, Yuanhan Mo, Aimee Readie, et al.. (2024). VertXNet: an ensemble method for vertebral body segmentation and identification from cervical and lumbar spinal X-rays. Scientific Reports. 14(1). 3341–3341. 11 indexed citations
3.
4.
Braun, Jürgen, Ricardo Blanco, Helena Marzo‐Ortega, et al.. (2023). Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis. Arthritis Research & Therapy. 25(1). 80–80. 9 indexed citations
5.
Shestopaloff, Konstantin, Benjamin Hollis, Nicole Hartmann, et al.. (2023). Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic background. The American Journal of Human Genetics. 110(10). 1817–1824. 6 indexed citations
6.
Baraliakos, Xenofon, Mikkel Østergaard, Denis Poddubnyy, et al.. (2023). OP0059 EFFECT OF SECUKINUMAB VERSUS ADALIMUMAB BIOSIMILAR ON RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A RANDOMISED PHASE IIIB STUDY. Annals of the Rheumatic Diseases. 82. 38–40. 4 indexed citations
7.
8.
Baraliakos, Xenofon, Mikkel Østergaard, Lianne S. Gensler, et al.. (2020). Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS). Clinical Drug Investigation. 40(3). 269–278. 33 indexed citations
9.
Heijde, Désirée van der, Philip J. Mease, Robert Landewé, et al.. (2019). Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5. Lara D. Veeken. 59(6). 1325–1334. 45 indexed citations
10.
Braun, Jürgen, Hildrun Haibel, Manouk de Hooge, et al.. (2019). Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison. Arthritis Research & Therapy. 21(1). 142–142. 31 indexed citations
11.
Mease, Philip J., Désirée van der Heijde, Robert Landewé, et al.. (2018). Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study. Annals of the Rheumatic Diseases. 77(6). 890–897. 221 indexed citations
12.
Braun, Joseph M., Hildrun Haibel, Manouk de Hooge, et al.. (2018). SAT0259 Low rate of spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison. Annals of the Rheumatic Diseases. 77. 992–993. 3 indexed citations
13.
Heijde, Désirée van der, Jürgen Braun, Atul Deodhar, et al.. (2018). Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis. Lara D. Veeken. 58(3). 388–400. 108 indexed citations
14.
Heijde, D. van der, Philip J. Mease, Robert Landewé, et al.. (2018). OP0306 Subcutaneous secukinumab inhibits radiographic progression in psoriatic arthritis: analysis by prior anti-tnf therapy and concomitant methotrexate use. Annals of the Rheumatic Diseases. 77. 199–200. 1 indexed citations
15.
Kivitz, Alan, Eva Dokoupilová, Ricardo Blanco, et al.. (2017). Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3. Arthritis Research & Therapy. 19(1). 285–285. 162 indexed citations
16.
Marzo‐Ortega, Helena, Joachim Sieper, Alan Kivitz, et al.. (2017). Secukinumab and Sustained Improvement in Signs and Symptoms of Patients With Active Ankylosing Spondylitis Through Two Years: Results From a Phase III Study. Arthritis Care & Research. 69(7). 1020–1029. 76 indexed citations
17.
Braun, Jürgen, Xenofon Baraliakos, Atul Deodhar, et al.. (2016). Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study. Annals of the Rheumatic Diseases. 76(6). 1070–1077. 188 indexed citations
18.
Deodhar, Atul, Maxime Dougados, Dominique Baeten, et al.. (2016). Effect of Secukinumab on Patient‐Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1). Arthritis & Rheumatology. 68(12). 2901–2910. 64 indexed citations
19.
20.
Cosman, Felicia, Erik Fink Eriksen, Chris Recknor, et al.. (2010). Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis. Journal of Bone and Mineral Research. 26(3). 503–511. 254 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Herbert Kellner Breakdown of academic impact, for papers by A. Nzeusseu Toukap Breakdown of academic impact, for papers by E. K. Li Breakdown of academic impact, for papers by S Songcharoen Breakdown of academic impact, for papers by Phil Gallagher Breakdown of academic impact, for papers by Debby den Uyl Breakdown of academic impact, for papers by J. S. Smolen Breakdown of academic impact, for papers by G. Schett Breakdown of academic impact, for papers by M. Witt Breakdown of academic impact, for papers by Yasushi Nawata
Rankless by CCL
2026